Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    05-14-2021 DEFA14A

    Additional proxy soliciting materials - definitive

    View HTML
    0001401914-21-000083.pdf
    0001401914-21-000083.xls
    05-13-2021 10-Q

    Quarterly report which provides a continuing view of a company's financial position

    View HTML
    0001401914-21-000080.pdf
    0001401914-21-000080.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    04-23-2021 PRE 14A

    A preliminary proxy statement providing notification matters to be brought to a vote

    View HTML
    0001401914-21-000073.pdf
    0001401914-21-000073.xls
    04-20-2021 3

    Initial filing by director officer or owner of more than ten percent.

    View HTML
    0001401914-21-000067.pdf
    0001401914-21-000067.xls
    04-20-2021 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-21-000068.pdf
    0001401914-21-000068.xls
    04-19-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000064.pdf
    0001401914-21-000064.xls
    04-08-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000055.pdf
    0001401914-21-000055.xls
    04-08-2021 424B5

    Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

    View HTML
    0001401914-21-000056.pdf
    0001401914-21-000056.xls
    04-08-2021 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001401914-21-000061.pdf
    0001401914-21-000061.xls
    04-07-2021 EFFECT

    EFFECT

    View HTML
    9999999995-21-001332.pdf
    9999999995-21-001332.xls

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page Next ›
    • Last page Last »

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2022 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top